Multiple clinical trial milestones were achieved, including encouraging topline data for a Phase 2 trial in CCM, the first ...

Biotech industry leaders added to the Board of Directors, bringing deep expertise in drug discovery, neuroscience clinical development, and ...

She took to the job, and to the bay area, like a duck to water. Before long Julie was promoted to technical writer. In 1994, Syntex was purchased by Genentech and became the world's fourth-largest ...

Methods Mice with combined knockout of PKG1 and 2 were challenged with bleomycin and treated with the sGC stimulator BAY 41-2272. Fibroblasts were ... Novartis, Pfizer, Roche/Genentech, Sanofi/Genzyme ...

Data shows Latino and Black people make up nearly 30% of the Bay Area population but only about 10% of active medical ...

The restructuring arrives during a period of turmoil at South San Francisco-based 23andMe, which has recently included a high ...

JLL said VC investment in the Bay Area’s life sciences and technology research sectors is beginning to rebound, with $35.4 ...

Layoffs sharply decreased between the first and second halves of the year, painting a fairly optimistic economic picture for the county, despite relatively flat venture capital funding levels last ...

Genentech, a South Bay-spawned global pharmaceutical firm, first made the joint announcement in March due to its Swiss parent company, the Roche Group, wanting to move its “large-scale ...

Enphase Energy, based in the Bay Area's Fremont, is laying off about 500 workers and pulling manufacturing from Guadalajara.